All of the candidates being considered by President Trump for FDA Commissioner believe that the FDA is too strict in its standards for approving new drugs. In a commentary in Nature last week, two bioethicists argued that, at least in terms of preclinical data, the standard of evidence is actually too low. Which is correct?
Search: “debate”
We found 893 results for your search.
I always wondered how low Donald Trump could go. Now I know. Only I fear this is nowhere near the bottom.
Share this:
In a (very) few short hours, Donald Trump will take the oath of office and become the 45th President of the United States. I realize that I don’t normally blog about politics, at least other than that related to medicine, but I make no bones about it. I’m dreading 12 Noon ET on January 20, […]
Share this:
So I was distracted yesterday from what I had intended to write about by an irresistible target provided me courtesy of Toby Cosgrove, MD, CEO of The Cleveland Clinic, who bemoaned all those nasty pro-science advocates who had had the temerity to link the antivaccine rant by the director of the Clinic’s Wellness Institute to […]
Share this:
\I’ve written quite a bit about how our soon-to-be President Donald Trump has consistently expressed antivaccine views over the years, such as his oft-stated (on Twitter and elsewhere) beliefs that it’s a “monster” shot that causes autism and infants get “too many” vaccines “too soon.” I’ve heard Trump supporters who are pro-vaccine pooh-pooh these statements […]
